Shares of Amdocs Limited (NASDAQ:DOX – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the five research firms that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $101.20.
A number of equities research analysts recently weighed in on DOX shares. Barclays lowered their price target on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a report on Thursday, November 14th. Oppenheimer raised their price target on shares of Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. Finally, StockNews.com lowered shares of Amdocs from a “strong-buy” rating to a “buy” rating in a report on Friday.
View Our Latest Analysis on Amdocs
Amdocs Stock Performance
Amdocs (NASDAQ:DOX – Get Free Report) last issued its earnings results on Tuesday, February 4th. The technology company reported $1.45 EPS for the quarter, missing analysts’ consensus estimates of $1.64 by ($0.19). Amdocs had a net margin of 10.19% and a return on equity of 18.89%. On average, research analysts predict that Amdocs will post 6.21 earnings per share for the current year.
Amdocs Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Sunday, April 20th. Investors of record on Monday, March 31st will be issued a dividend of $0.527 per share. This represents a $2.11 dividend on an annualized basis and a yield of 2.42%. This is a positive change from Amdocs’s previous quarterly dividend of $0.48. The ex-dividend date is Monday, March 31st. Amdocs’s dividend payout ratio (DPR) is presently 48.72%.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in DOX. Private Advisor Group LLC grew its holdings in Amdocs by 3.2% during the 3rd quarter. Private Advisor Group LLC now owns 5,626 shares of the technology company’s stock worth $492,000 after acquiring an additional 175 shares in the last quarter. First Trust Direct Indexing L.P. grew its holdings in Amdocs by 7.0% during the 3rd quarter. First Trust Direct Indexing L.P. now owns 3,063 shares of the technology company’s stock worth $268,000 after acquiring an additional 200 shares in the last quarter. Deroy & Devereaux Private Investment Counsel Inc. grew its holdings in Amdocs by 1.0% during the 3rd quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 299,250 shares of the technology company’s stock worth $26,178,000 after acquiring an additional 2,890 shares in the last quarter. Rice Hall James & Associates LLC grew its holdings in Amdocs by 338.3% during the 3rd quarter. Rice Hall James & Associates LLC now owns 167,023 shares of the technology company’s stock worth $14,611,000 after acquiring an additional 128,919 shares in the last quarter. Finally, Affinity Investment Advisors LLC grew its holdings in Amdocs by 19.3% during the 3rd quarter. Affinity Investment Advisors LLC now owns 8,605 shares of the technology company’s stock worth $753,000 after acquiring an additional 1,393 shares in the last quarter. 92.02% of the stock is owned by institutional investors and hedge funds.
Amdocs Company Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
See Also
- Five stocks we like better than Amdocs
- Why Invest in 5G? How to Invest in 5G Stocks
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- 3 REITs to Buy and Hold for the Long Term
- 5 Best Gold ETFs for March to Curb Recession Fears
- 3 Warren Buffett Stocks to Buy Now
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.